{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:41:25Z","timestamp":1792453285449,"version":"4.5.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.1541","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T12:25:31Z","timestamp":1585052731000},"page":"e201541","source":"Crossref","is-referenced-by-count":55,"title":["Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women With Breast Cancer"],"prefix":"10.1001","volume":"3","author":[{"given":"Gregory L.","family":"Branigan","sequence":"first","affiliation":[{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson"},{"name":"Department of Pharmacology, University of Arizona College of Medicine, Tucson"},{"name":"MD-PhD Training Program, University of Arizona College of Medicine, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Soto","sequence":"additional","affiliation":[{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson"},{"name":"Department of Pharmacology, University of Arizona College of Medicine, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Neumayer","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Arizona College of Medicine, Tucson"},{"name":"Department of Obstetrics and Gynecology, University of Arizona College of Medicine, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson"},{"name":"Department of Pharmacology, University of Arizona College of Medicine, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Diaz","family":"Brinton","sequence":"additional","affiliation":[{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson"},{"name":"Department of Pharmacology, University of Arizona College of Medicine, Tucson"},{"name":"Department of Neurology, University of Arizona College of Medicine, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"issue":"1","key":"zoi200081r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v69.1","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"zoi200081r3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer epidemiology and risk factors.","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"zoi200081r4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fnagi.2015.00168","article-title":"Age-related neurodegenerative disease research needs aging models.","volume":"7","author":"Johnson","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"17","key":"zoi200081r5","doi-asserted-by":"publisher","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease.","volume":"22","author":"Niccoli","year":"2012","journal-title":"Curr Biol"},{"key":"zoi200081r6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","article-title":"Age, APOE and sex: triad of risk of Alzheimer\u2019s disease.","volume":"160","author":"Riedel","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"zoi200081r7","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data.","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"zoi200081r8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1212\/WNL.58.1.136","article-title":"Prevalence estimates for MS in the United States and evidence of an increasing trend for women.","volume":"58","author":"Noonan","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"zoi200081r9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer\u2019s disease facts and figures.","volume":"14","author":"Alzheimer's Association","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi200081r10","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.21873\/invivo.11615","article-title":"Cognitive functioning and psychological well-being in breast cancer patients on endocrine therapy.","volume":"33","author":"Biro","year":"2019","journal-title":"In Vivo"},{"issue":"1","key":"zoi200081r11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaoncol.2016.3662","article-title":"Association between androgen deprivation therapy and risk of dementia.","volume":"3","author":"Nead","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"zoi200081r14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/hcv072","article-title":"Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study.","volume":"109","author":"Sun","year":"2016","journal-title":"QJM"},{"key":"zoi200081r15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fphar.2017.00612","article-title":"Nationwide case-control study examining the association between tamoxifen use and Alzheimer\u2019s disease in aged women with breast cancer in Taiwan.","volume":"8","author":"Liao","year":"2017","journal-title":"Front Pharmacol"},{"key":"zoi200081r16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2377-10-23","article-title":"Risk of Parkinson\u2019s disease after tamoxifen treatment.","volume":"10","author":"Latourelle","year":"2010","journal-title":"BMC Neurol"},{"key":"zoi200081r17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.dadm.2017.10.002","article-title":"Probability of Alzheimer\u2019s disease in breast cancer survivors based on gray-matter structural network efficiency.","volume":"9","author":"Kesler","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"22","key":"zoi200081r18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.0000000000002171","article-title":"Raloxifene for women with Alzheimer disease: a randomized controlled pilot trial.","volume":"85","author":"Henderson","year":"2015","journal-title":"Neurology"},{"issue":"9025","key":"zoi200081r19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","article-title":"Effect of oestrogen during menopause on risk and age at onset of Alzheimer\u2019s disease.","volume":"348","author":"Tang","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"zoi200081r21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0093-7754(03)00302-6","article-title":"Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.","volume":"30","author":"Miller","year":"2003","journal-title":"Semin Oncol"},{"issue":"6","key":"zoi200081r23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2165\/00002512-200219060-00002","article-title":"Estrogen and Alzheimer\u2019s disease: the story so far.","volume":"19","author":"Cholerton","year":"2002","journal-title":"Drugs Aging"},{"issue":"1","key":"zoi200081r24","first-page":"51","article-title":"Practice guidelines for the diagnosis and treatment of Alzheimer\u2019s disease in a managed care setting: part II\u2014pharmacologic therapy.","volume":"13","author":"Fillit","year":"2000","journal-title":"Manag Care Interface"},{"issue":"17","key":"zoi200081r25","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/archinte.162.17.1934","article-title":"The role of hormone replacement therapy in the prevention of Alzheimer disease.","volume":"162","author":"Fillit","year":"2002","journal-title":"Arch Intern Med"},{"issue":"5","key":"zoi200081r26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11910-010-0122-6","article-title":"Hormonal influences on cognition and risk for Alzheimer\u2019s disease.","volume":"10","author":"Janicki","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"zoi200081r27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2017.05.059","article-title":"Estrogen and Alzheimer\u2019s disease: still an attractive topic despite disappointment from early clinical results.","volume":"817","author":"Merlo","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"zoi200081r28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial: Alzheimer\u2019s Disease Cooperative Study.","volume":"283","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"zoi200081r29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1756285608100427","article-title":"The potential for estrogens in preventing Alzheimer\u2019s disease and vascular dementia.","volume":"2","author":"Simpkins","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"zoi200081r30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, neuroinflammation, and neurodegeneration.","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr Rev"},{"issue":"17","key":"zoi200081r31","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"zoi200081r32","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1124\/jpet.106.109504","article-title":"Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.","volume":"319","author":"Zhao","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"zoi200081r33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","article-title":"Perimenopause as a neurological transition state.","volume":"11","author":"Brinton","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"zoi200081r34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.breast.2016.06.013","article-title":"A prospective study on the neurological complications of breast cancer and its treatment: updated analysis three years after cancer diagnosis.","volume":"29","author":"Fontes","year":"2016","journal-title":"Breast"},{"issue":"1","key":"zoi200081r35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1037\/a0025539","article-title":"Estrogen and cognitive functioning in women: lessons we have learned.","volume":"126","author":"Sherwin","year":"2012","journal-title":"Behav Neurosci"},{"issue":"20","key":"zoi200081r36","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"zoi200081r37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yhbeh.2015.04.018","article-title":"Postmenopausal hormone therapy and cognition.","volume":"74","author":"McCarrey","year":"2015","journal-title":"Horm Behav"},{"issue":"20","key":"zoi200081r38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Rapp","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"zoi200081r39","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1210\/en.2006-0495","article-title":"Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications.","volume":"147","author":"Chen","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"zoi200081r40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J013v31n01_05","article-title":"The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents.","volume":"31","author":"Breuer","year":"2000","journal-title":"Women Health"},{"issue":"4","key":"zoi200081r41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.maturitas.2004.08.004","article-title":"Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.","volume":"50","author":"Vogelvang","year":"2005","journal-title":"Maturitas"},{"issue":"5","key":"zoi200081r42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ijnp\/pyx008","article-title":"The working memory and dorsolateral prefrontal-hippocampal functional connectivity changes in long-term survival breast cancer patients treated with tamoxifen.","volume":"20","author":"Chen","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"zoi200081r43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-015-3493-1","article-title":"A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.","volume":"152","author":"Le Rhun","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"zoi200081r44","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Early discontinuation of tamoxifen: a lesson for oncologists.","volume":"109","author":"Barron","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"zoi200081r45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0301-2115(98)00278-4","article-title":"Pharmacokinetics of raloxifene and its clinical application.","volume":"85","author":"Hochner-Celnikier","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"zoi200081r46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0306-4530(98)00041-9","article-title":"Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.","volume":"24","author":"Nickelsen","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"zoi200081r47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/(ISSN)1749-6632","article-title":"Estrogens, selective estrogen receptor modulators, and dementia: what is the evidence?","volume":"949","author":"Yaffe","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"zoi200081r48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/humupd\/6.3.244","article-title":"The endometrial effects of SERMs.","volume":"6","author":"Cano","year":"2000","journal-title":"Hum Reprod Update"},{"issue":"4","key":"zoi200081r49","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3892\/ol.2015.2962","article-title":"Molecular mechanisms of tamoxifen-associated endometrial cancer.","volume":"9","author":"Hu","year":"2015","journal-title":"Oncol Lett"},{"issue":"1","key":"zoi200081r50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","article-title":"The effect of tamoxifen on the genital tract.","volume":"8","author":"Polin","year":"2008","journal-title":"Cancer Imaging"},{"key":"zoi200081r51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1874325000903010014","article-title":"Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice.","volume":"3","author":"Rey","year":"2009","journal-title":"Open Orthop J"},{"issue":"1","key":"zoi200081r52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.expneurol.2003.09.005","article-title":"Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer\u2019s disease.","volume":"185","author":"O\u2019Neill","year":"2004","journal-title":"Exp Neurol"},{"issue":"2","key":"zoi200081r53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.expneurol.2004.01.014","article-title":"Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer\u2019s disease.","volume":"188","author":"O\u2019Neill","year":"2004","journal-title":"Exp Neurol"},{"issue":"5","key":"zoi200081r54","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1523\/JNEUROSCI.0353-18.2018","article-title":"Adverse effects of aromatase inhibition on the brain and behavior in a nonhuman primate.","volume":"39","author":"Gervais","year":"2019","journal-title":"J Neurosci"},{"issue":"11","key":"zoi200081r55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/jgs.1999.47.issue-11","article-title":"Cognitive function and endogenous sex hormones in older women.","volume":"47","author":"Barrett-Connor","year":"1999","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"zoi200081r56","first-page":"3681","article-title":"Endogenous sex hormones and cognitive function in older men.","volume":"84","author":"Barrett-Connor","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi200081r57","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/1940-6207.CAPR-13-0389","article-title":"Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.","volume":"7","author":"Chlebowski","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"zoi200081r58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer\u2019s disease drug development pipeline: 2018.","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"zoi200081r2","unstructured":"Surveillance, Epidemiology, and End Results Program. SEER cancer statistics review (CSR) 1975-2016. Accessed January 1, 2020. https:\/\/seer.cancer.gov\/csr\/1975_2016\/"},{"key":"zoi200081r12","unstructured":"National Comprehensive Cancer Network. Practice guidelines in oncology: breast cancer: version 2.2017. Accessed September 15, 2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_blocks.pdf"},{"key":"zoi200081r13","unstructured":"ChenWY. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention. UpToDate. Accessed July 31, 2019. https:\/\/www.uptodate.com\/contents\/selective-estrogen-receptor-modulators-and-aromatase-inhibitors-for-breast-cancer-prevention"},{"key":"zoi200081r20","unstructured":"PearlDiver. Healthcare research. Accessed February 11, 2020. http:\/\/www.pearldiverinc.com"},{"key":"zoi200081r22","unstructured":"Office of the Assistant Secretary for Planning and Evaluation. National plan to address Alzheimer\u2019s disease: 2018 update. Accessed January 1, 2020. https:\/\/aspe.hhs.gov\/report\/national-plan-address-alzheimers-disease-2018-update"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2763234\/branigan_2020_oi_200081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T17:37:18Z","timestamp":1614965838000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2763234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.1541","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737615009.793573317","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.737615009.793572960","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}